Alligator Bioscience AB: Last day of trading in paid subscription shares (Sw BTA) finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Notice of the Annual General Meeting
News provided by
Share this article
STOCKHOLM, Feb. 18, 2021 /PRNewswire/
Notice is given to the Shareholders of Essity Aktiebolag (publ) ( Essity ) of the Annual General Meeting of Shareholders to be held on Thursday, March 25, 2021
Due to the current pandemic, the Annual General Meeting will, in accordance with temporary legislation, be held only by advance voting (postal voting). Hence, shareholders will not be able to physically attend the Meeting in person or by proxy. Instead, Essity welcomes shareholders to exercise their voting rights at the Meeting by advance voting in the manner described below. Information on the resolutions passed at the Meeting will be disclosed on 25 March 2021, as soon as the outcome of the advance voting has been finally confirmed.
(2)
The Board of Directors in Hoylu AB (publ) ( Hoylu or the Company ) has today, based on the authorization granted by the Annual General Meeting on 25 June 2020, resolved, and carried out, a directed share issue of approximately SEK 28.5 million (the Private Placement ).
In addition, the Board of Directors resolved, subject to the subsequent approval by the shareholders on an extraordinary general meeting, to carry out a directed share issue of up to 535,713 new shares to the Deputy CEO Truls Baklid and the board member Hans Othar Blix (the Directed Share Issue ). The Board of Directors intends to summon shareholders to an extraordinary general meeting to resolve on the Directed Share Issue. The notice of the extraordinary general meeting will be issued separately, together with complete terms and conditions of the Directed Share Issue.
Swedish
The Board of Directors in Hoylu AB (publ) (“Hoylu” or the “Company”) has today, based on the authorization granted by the Annual General Meeting on 25 June 2020, resolved, and carried out, a directed share issue of approximately SEK 28.5 million (the “Private Placement”).
In addition, the Board of Directors resolved, subject to the subsequent approval by the shareholders on an extraordinary general meeting, to carry out a directed share issue of up to 535,713 new shares to the Deputy CEO Truls Baklid and the board member Hans Othar Blix (the “Directed Share Issue”). The Board of Directors intends to summon shareholders to an extraordinary general meeting to resolve on the Directed Share Issue. The notice of the extraordinary general meeting will be issued separately, together with complete terms and conditions of the Directed Share Issue.
Alligator Bioscience s rights issue oversubscribed
STOCKHOLM, Jan. 27, 2021 /PRNewswire/
Alligator Bioscience AB (publ) ( Alligator or the Company ) has completed the share issue with pre-emption rights for the Company s shareholders, which was resolved upon by the Board of Directors on December 15, 2020 pursuant to the authorization from the annual general meeting on May 5, 2020 (the Rights Issue ). The subscription period ran from and including January 11, 2021 to and including January 25, 2021. Through the Rights Issue, Alligator receives approximately SEK 86 million before deduction of issue costs. 13 895 925 shares, corresponding to approximately 97 per cent of the Rights Issue, were subscribed for by exercise of subscription rights (including subscription undertakings). Furthermore, 9 305 467 shares were subscribed for without subscription rights, corresponding to approximately 65 per cent of the Rights Issue. In total, the Rights Issue was subscribed for at 163 per cen